CN Stock MarketDetailed Quotes
000623 Jilin Aodong Pharmaceutical Group
- 17.87
- +0.15+0.85%
Not Open Dec 27 15:00 CST
21.37BMarket Cap14.94P/E (TTM)
18.04High17.68Low79.83KlotVolume17.70Open17.72Pre Close142.61MTurnover0.67%Turnover Ratio14.64P/E (Static)1.20BShares19.9852wk High0.74P/B21.28BFloat Cap12.2952wk Low19.49Limit Up1.19BShs Float42.48Historical High15.95Limit Down2.03%Amplitude-2.44Historical Low0.80Dividend TTM17.86Avg Price34.65KlotAsk4.48%Div YieldTTM100Lot Size44.15KlotBid
Jilin Aodong Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -31.78%1.27B | 4.59%2.03B | 46.35%1.63B | 19.59%1.72B | 23.31%1.86B | 50.98%1.94B | -32.33%1.12B | -17.46%1.44B | -8.68%1.51B | -13.30%1.28B |
| Transactional financial assets | -3.60%1.7B | -29.22%1.23B | -15.42%1.45B | 1.11%1.66B | 16.89%1.76B | -5.89%1.74B | -10.46%1.71B | -25.08%1.64B | -41.01%1.51B | -16.81%1.85B |
| Notes receivable and accounts receivable | -9.48%971.58M | 19.16%1.11B | 35.87%1.32B | 30.07%1.01B | 22.24%1.07B | 12.01%932.33M | 20.33%971.68M | 26.36%776.64M | -3.14%878.02M | -0.09%832.38M |
| -Notes receivable | --154.5K | -93.04%316.78K | -99.91%101.15K | ---- | ---- | --4.55M | --111.78M | --88.13M | ---- | ---- |
| -Accounts receivable | -9.49%971.43M | 19.71%1.11B | 53.51%1.32B | 46.72%1.01B | 22.24%1.07B | 11.46%927.78M | 6.49%859.9M | 12.02%688.51M | 31.97%878.02M | 23.53%832.38M |
| Other receivables (including interest and dividends) | -36.51%30.56M | -10.64%525.95M | -37.90%39.01M | -50.28%29.98M | -34.95%48.13M | -22.21%588.6M | -21.75%62.82M | -12.00%60.31M | -11.54%73.99M | 8.82%756.63M |
| -Dividend receivable | ---- | -6.07%494.05M | --555.84K | ---- | --9.6M | -23.56%526M | ---- | ---- | ---- | 11.11%688.15M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | -18.43%12.67M | 2.44%11.84M | 14.93%8.59M | 18.42%4.02M |
| -Other receivable | ---- | -49.04%31.89M | ---- | ---- | ---- | -2.90%62.59M | ---- | -14.93%48.46M | ---- | -11.21%64.47M |
| Advance payment | -6.12%87.06M | -19.73%77.97M | -57.33%60.21M | -60.82%43.38M | -18.52%92.73M | -25.10%97.13M | 152.50%141.12M | 240.69%110.72M | 136.27%113.81M | 200.70%129.68M |
| Inventories | 8.06%1.01B | 6.88%972.31M | 0.76%889.09M | -0.25%872.35M | 18.22%932.33M | 21.96%909.74M | 41.31%882.34M | 47.76%874.57M | 25.93%788.66M | 21.68%745.94M |
| Receivable financing | -53.15%210.62M | -67.68%150.23M | -36.88%147.59M | 41.94%396.77M | 160.59%449.55M | 121.79%464.79M | -41.77%233.82M | -20.07%279.54M | --172.52M | --209.57M |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10M | --10M |
| Other current assets | 32.51%18.64M | 321.30%18.32M | -97.69%18.37M | -98.23%14.17M | -98.23%14.07M | -99.46%4.35M | 11.10%795.88M | 10.27%801.97M | 9.05%795.28M | 9.36%798.44M |
| Total current assets | -15.06%5.29B | -8.40%6.12B | -6.09%5.55B | -3.96%5.75B | 6.56%6.23B | 0.91%6.68B | -5.45%5.91B | -5.44%5.98B | -11.41%5.85B | -0.04%6.62B |
| Non Current assets | ||||||||||
| Other equity investment | -22.03%305.6M | -20.66%312.6M | -14.25%338.61M | -12.16%338.99M | -4.18%391.93M | -21.31%393.98M | -24.67%394.88M | -27.06%385.9M | -18.81%409.03M | 1.19%500.65M |
| Investment real estate | -14.28%22.45M | -5.67%22.95M | 3.26%25.47M | 3.30%25.83M | -8.59%26.19M | -16.15%24.33M | -16.05%24.67M | -13.16%25.01M | 0.61%28.65M | 1.43%29.02M |
| Long-term equity investment | 7.09%23.72B | 6.15%23.32B | 5.33%23.1B | 5.39%22.66B | 8.74%22.15B | 14.69%21.97B | 13.74%21.93B | 12.54%21.5B | 8.96%20.37B | 5.39%19.16B |
| Fixed assets | ---- | 0.07%2.11B | ---- | ---- | ---- | 5.18%2.11B | ---- | 2.93%2.11B | ---- | -2.80%2B |
| Constru in process | ---- | 130.10%415.82M | ---- | ---- | ---- | -7.08%180.72M | ---- | -1.09%177.36M | ---- | 67.88%194.48M |
| Productive biological assets | -16.14%5.47M | -17.34%5.62M | -17.10%5.98M | -21.19%6.04M | -21.10%6.53M | -18.48%6.8M | -17.99%7.21M | -15.85%7.66M | -15.41%8.27M | -16.83%8.34M |
| Intangible assets | 32.11%452.69M | 31.14%457.98M | 26.39%464.53M | 19.25%435.35M | -7.71%342.67M | -7.63%349.23M | -1.04%367.54M | 1.52%365.08M | 1.19%371.29M | 12.69%378.09M |
| Development expenditure | -41.28%137.77M | -41.80%133.45M | -41.90%124.88M | -20.61%155.71M | 31.43%234.63M | 33.95%229.29M | 29.00%214.93M | 14.16%196.14M | 31.60%178.52M | 33.79%171.18M |
| Long deferred expense | -50.43%6.76M | -49.86%7.22M | -51.33%7.28M | -48.79%8.25M | -15.86%13.64M | -4.15%14.4M | -4.66%14.95M | -0.67%16.11M | 17.87%16.21M | 4.57%15.03M |
| Deferred tax assets | 8.20%300.97M | 42.01%393.45M | 21.40%348M | 2.22%309.84M | -14.84%278.15M | 3.76%277.06M | 25.49%286.66M | 84.53%303.12M | 210.09%326.62M | 92.02%267M |
| Usufruct assets | 8.34%50.29M | -1.34%48.45M | -14.78%44.47M | 2.53%47.39M | -7.13%46.42M | -11.82%49.11M | -7.17%52.18M | -22.77%46.23M | -5.89%49.98M | 6.84%55.69M |
| Other non current assets | -48.48%82.22M | 21.92%79.97M | 42.73%79.13M | -22.95%49.94M | 42.19%159.59M | -25.59%65.59M | -35.45%55.44M | -4.30%64.82M | -7.03%112.24M | -20.10%88.15M |
| Total non current assets | 6.43%27.6B | 6.39%27.31B | 5.43%27.01B | 5.24%26.52B | 7.78%25.94B | 12.25%25.67B | 11.52%25.62B | 10.81%25.2B | 8.47%24.07B | 5.54%22.87B |
| Total assets | 2.26%32.9B | 3.34%33.42B | 3.27%32.56B | 3.48%32.27B | 7.54%32.17B | 9.70%32.34B | 7.89%31.53B | 7.27%31.18B | 3.91%29.91B | 4.24%29.48B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 46.23%1.14B | 39.27%1.12B | 138.07%1.67B | 4.15%678.31M | 33.89%778.17M | 64.33%803.78M | 53.86%700.95M | 83.19%651.27M | 63.25%581.22M | 30.83%489.11M |
| Notes payable and accounts payable | 3.87%427.01M | 6.34%443.4M | -27.78%297.79M | -7.18%418.59M | 18.22%411.1M | 4.85%416.98M | 40.82%412.35M | 89.31%450.97M | 36.38%347.75M | 46.98%397.68M |
| -Notes payable | -69.87%3.89M | -8.58%9.65M | -74.13%3.04M | -58.59%5.86M | -9.43%12.92M | -30.80%10.55M | -19.43%11.76M | -20.51%14.16M | -11.04%14.27M | 38.68%15.25M |
| -Accounts payable | 6.27%423.12M | 6.72%433.75M | -26.42%294.75M | -5.51%412.72M | 19.40%398.17M | 6.28%406.43M | 43.99%400.58M | 98.19%436.81M | 39.56%333.47M | 47.33%382.43M |
| Contract liabilities | 102.08%38.93M | 37.61%28.9M | 43.07%29.92M | -68.08%26.26M | 9.95%19.26M | 1.84%21M | 39.03%20.91M | 348.09%82.25M | -29.29%17.52M | -11.52%20.62M |
| Advance receipts | 7.03%1.87M | -7.07%1.1M | -96.72%959.68K | -96.52%1.01M | -94.02%1.75M | -95.96%1.19M | -19.78%29.29M | -21.06%29.02M | 1,836.34%29.18M | 1,014.97%29.39M |
| Salaries payable | -4.56%31.62M | -22.64%32.04M | -14.92%65.06M | -31.43%74.49M | -4.99%33.14M | 60.95%41.42M | 7.25%76.46M | 28.54%108.63M | -11.04%34.88M | -39.68%25.73M |
| Taxs payable | -59.30%22.45M | -57.59%14.82M | -7.47%40.58M | 20.81%67.08M | 2.27%55.16M | -19.51%34.93M | -21.17%43.85M | 76.25%55.53M | 75.81%53.93M | 50.98%43.4M |
| Other payable (including interest and dividends) | -19.82%670.85M | 26.94%1.46B | 29.97%947.38M | 7.09%866.16M | 26.11%836.68M | 74.20%1.15B | 11.15%728.93M | 21.96%808.79M | 8.82%663.45M | -24.55%658.32M |
| -Interest payable | -42.58%15.25M | -52.43%6.88M | -79.94%501.11K | 20.74%37.45M | 24.55%26.55M | 24.61%14.46M | 24.62%2.5M | 99.93%31.01M | 100.03%21.32M | 100.00%11.61M |
| -Dividend payable | 12,735.28%665.7K | 112.23%717.54M | 0.00%5.19K | 0.00%5.19K | 0.00%5.19K | 6,518,590.16%338.09M | 0.00%5.19K | 0.00%5.19K | 0.00%5.19K | -100.00%5.19K |
| -Other payable | -19.16%654.94M | -7.92%731.37M | 30.35%946.87M | 6.55%828.71M | 26.16%810.12M | 22.82%794.26M | 11.11%726.43M | 20.10%777.77M | 7.20%642.12M | 1.21%646.71M |
| Non current liabilities due within one year | -99.06%22.42M | -99.11%20.96M | -99.22%18.24M | 12,691.29%2.33B | 13,206.92%2.38B | 11,655.86%2.37B | 11,102.90%2.35B | -28.24%18.23M | -18.92%17.91M | -10.58%20.13M |
| Other current liabilities | 101.56%4.83M | 15,355.26%403.62M | 15,128.22%403.72M | -69.32%3.27M | 5.49%2.39M | -2.07%2.61M | 37.79%2.65M | 366.16%10.67M | -23.22%2.27M | -5.01%2.67M |
| Total current liabilities | -47.85%2.36B | -27.20%3.52B | -20.40%3.47B | 101.67%4.47B | 158.63%4.52B | 186.60%4.84B | 171.72%4.36B | 52.18%2.22B | 30.27%1.75B | 2.89%1.69B |
| Current liabilities | ||||||||||
| Bonds payable | --994.72M | --994.23M | ---- | ---- | ---- | ---- | ---- | 4.15%2.3B | 4.39%2.28B | 4.60%2.26B |
| Deferred tax liabilities | 138.92%30.64M | 80.43%29.38M | 65.50%29.13M | 15.26%30.03M | 104.64%12.82M | -20.23%16.28M | -21.36%17.6M | 7.65%26.06M | -88.13%6.27M | 46.84%20.41M |
| Long term deferred income | -16.04%229.48M | -11.93%234.84M | -13.06%240.7M | -12.15%247.38M | -5.81%273.33M | -10.59%266.65M | -8.10%276.87M | -10.28%281.6M | -4.75%290.19M | -8.05%298.24M |
| Lease liabilities | 2.85%22.97M | 5.68%21.82M | -8.83%19.15M | 22.45%21.49M | 9.03%22.34M | -19.05%20.65M | -17.18%21.01M | -24.94%17.55M | -5.68%20.48M | 14.52%25.51M |
| Total non current liabilities | 314.22%1.28B | 321.72%1.28B | -8.40%288.99M | -88.63%298.9M | -88.13%308.49M | -88.34%303.59M | -87.80%315.48M | 2.16%2.63B | 1.29%2.6B | 3.27%2.6B |
| Total liabilities | -24.72%3.64B | -6.58%4.8B | -19.60%3.76B | -1.60%4.77B | 11.12%4.83B | 19.78%5.14B | 11.63%4.68B | 20.24%4.84B | 11.25%4.35B | 3.12%4.29B |
| Shareholders equity | ||||||||||
| Paid-in capital | 2.81%1.2B | 2.82%1.2B | 6.70%1.24B | 0.46%1.17B | 0.01%1.16B | 0.00%1.16B | 0.00%1.16B | 0.00%1.16B | 0.00%1.16B | 0.00%1.16B |
| Other equity instruments | ---- | ---- | ---- | -3.14%542.29M | -0.07%559.65M | -0.04%559.85M | -0.03%559.86M | -0.03%559.87M | -0.00%560.05M | -0.00%560.05M |
| Capital reserve funds | 22.82%4.85B | 22.90%4.85B | 40.12%5.53B | 2.24%4.03B | 0.13%3.95B | 0.16%3.95B | -0.84%3.95B | -0.84%3.95B | -0.74%3.94B | -0.84%3.94B |
| Surplus reserve funds | 5.79%2.49B | 5.80%2.49B | 5.80%2.49B | 5.80%2.49B | 8.03%2.35B | 8.29%2.35B | 8.33%2.35B | 8.33%2.35B | 10.53%2.18B | 10.26%2.17B |
| Retained profit | 3.01%19.91B | 0.45%19.2B | 3.44%19.53B | 5.41%19.38B | 9.41%19.33B | 10.94%19.12B | 10.19%18.88B | 7.71%18.39B | 2.79%17.67B | 4.72%17.23B |
| Less:Treasury stock | ---- | ---- | 26.31%720.07M | 26.31%720.07M | 12.72%620.05M | 26.85%570.07M | 42.51%570.07M | 42.51%570.07M | 37.50%550.06M | 12.34%449.41M |
| Other composite income | 80.89%553.58M | 79.98%617M | 113.93%455.99M | 62.35%314.7M | -4.15%306.04M | 14.31%342.81M | -14.94%213.15M | -38.08%193.84M | 30.81%319.28M | 37.29%299.91M |
| Shareholders equity without minority interests | 7.25%29B | 5.37%28.36B | 7.46%28.52B | 4.52%27.21B | 6.96%27.04B | 8.00%26.91B | 6.78%26.54B | 4.72%26.03B | 2.36%25.28B | 4.08%24.92B |
| Minority interests | -12.54%261.78M | -8.69%268.67M | -10.13%277M | -5.12%288.01M | 4.31%299.3M | 6.66%294.25M | 76.18%308.22M | 69.33%303.54M | 56.94%286.95M | 49.15%275.88M |
| Total shareholder equity | 7.03%29.26B | 5.21%28.62B | 7.26%28.8B | 4.41%27.5B | 6.93%27.34B | 7.98%27.21B | 7.27%26.85B | 5.19%26.34B | 2.76%25.57B | 4.43%25.19B |
| Total liabilityies and equity | 2.26%32.9B | 3.34%33.42B | 3.27%32.56B | 3.48%32.27B | 7.54%32.17B | 9.70%32.34B | 7.89%31.53B | 7.27%31.18B | 3.91%29.91B | 4.24%29.48B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongzhun Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongzhun Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
